Fibrin Matrix Therapy Products in Las Vegas, NV

CDC PLACES vs. JE: two files, not one brochure

CDC PLACES (2023, crude) estimates 12.5% of adults in Las Vegas have diagnosed diabetes — 0.5 points above the U.S. 12% figure. Census city-proper population is 646,790. If you are adding fibrin matrix therapy, start with that epidemiology and with Noridian Healthcare Solutions (JE) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Epidemiology is not a protocol

• CDC PLACES (2023, crude) estimates 12.5% of adults in Las Vegas have diagnosed diabetes — 0.5 points above the U.S. 12% figure. Adult obesity in Las Vegas is 32.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JE review. Product is the last step, not the first.
• Orthopedic and wound-care buyers in Nevada are often different people inside the same health system. A single Hawk Medical account can still require two utilization policies so 361 tissue and CTPs are not interchanged.
• City-proper population of 646,790 is a Census figure, not a clinic count. It tells you the size of the catchment, not how many biologic vendors already call on the orthopedic group down the street.

What CDC PLACES and JE each actually tell you

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Las Vegas we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 12.5% of adults in Las Vegas have diagnosed diabetes — 0.5 points above the U.S. 12% figure.

Before the first fibrin matrix therapy shipment